September 20, 2024, Medical Economics
Malpractice Caps and Nuclear Verdicts
Medical Economics Editorial Director Chris Mazzolini sits down with Bob White, President of The Doctors Company and TDC Group, to discuss trends in malpractice litigation and what recent verdicts mean for the industry at large.
Search
April 01, 2025, Healthcare Risk Management
Avoid the Common Pitfalls in Medical Documentation
Daniel Kent Cassavar, MD, MBA, FACC, Medical Director, The Doctors Company and TDC Group, discusses the importance of accurate and thorough healthcare documentation.
December 11, 2023, Part B News
Thwart Abuse: Consider Opt-out,Training in Chaperone Policy
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, provides policy suggestions for healthcare providers to implement that can help defend against sexual harassment allegations.
May 20, 2024, Part B News
Must You Rehire Suspended Providers Who Get Their License Back? Look to Contract
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, provides insight on how practices should respond when suspended providers get their licenses back.
November 01, 2023, Healthcare Risk Management
How to Identify and Defend Against Malicious Lawsuits
Richard F. Cahill, Esq., Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses common concerns healthcare professionals have when it comes to disgruntled patients and malicious lawsuits.
March 05, 2024, Business Insurance
Alabama Embryo Ruling May Increase Med Mal Risks
Robert White, President of The Doctors Company and TDC Group, discusses the potential impacts the recent IVF ruling in Alabama will have on healthcare professionals.
November 28, 2023, Crico
Higher Malpractice Risk with Advanced Practice Providers? Data Say Not Really
Does the increased prevalence of non-physician patient care mean an increased risk to patient safety?
Effective Patient-Assisted Telehealth Assessments
Physicians who practice telemedicine must consider the components needed to complete an effective remote assessment and plan ahead based on their specialty area and the patient’s presenting complaint.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Mar 04, 2024
Patient Safety Impact Story: Documentation Can Prevent Litigation
Our experts partnered with a general surgery practice to dramatically improve its after-hours call documentation rate.
From
The Doctor’s Advocate
